🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congrats on another amazing class selection Yale University Yale School of Medicine under leadership of Mark D. Siegel setting yet another big example of inclusion and equity for some amazing #IMGs ! Other Ivy League schools should pay notice Toni Choueiri, MD

Join us for an important webinar on April 9 featuring leading experts and a #sarcoma survivor sharing insights on chondrosarcoma research, treatment, and patient perspectives. This session is a great opportunity to learn, ask questions, and connect with others. #CureSarcoma

We love pembrolizumab, osimertinib, tarlatamab—and rightly so. But quitting smoking still saves more lives than any of them. It deserves way more airtime.

Our next #CME webinar is this Thursday at 6pm on #sarcoma. Hear from our experts on the latest advances in sarcoma research and breakthroughs. RSVP: bit.ly/4ja3Xhv Smilow Cancer Hospital Yale School of Medicine Yale New Haven Hosp Yale IR Yale Department of Orthopaedics and Rehabilitation Kelly Olino

Two Brazilian oncologists, Adriana Kahn, MD, YaleBreastCancer, + Dr. Philippos Costa Philippos Apolinario Costa, MD, Yale Hematology Oncology Fellows fellow, are among international clinical-scientists at Yale Cancer Center working to expand knowledge + improve treatments for pts with #cancer. world.yale.edu/news/brazilian…

☝️ EHE 360 IS ONE WEEK AWAY, and ASK THE EXPERT is back, and there is still time to submit questions to our #EHE expert panel for #EHE360!⁠ Submit your questions as you register: 🔗 fightehe.org/ehe-360/ ⁠ #EHE360 #epithelioidhemangioendothelioma #EHEcancer #justlive

Adriana Kahn and Philippos Costa contribute to advancing cancer treatment at Yale Cancer Center Yale Cancer Center Adriana Kahn, MD Philippos Apolinario Costa, MD oncodaily.com/blog/adriana-k… #Cancer #Oncology #OncoDaily #Health #Medicine #MedEd #MedX #MedNews

While ICI-based regimens have improved outcomes for patients with met RCC, in this review David Braun + Zachary Yochum discuss SOC, ongoing #clinicaltrials, + potential of novel therapies to improve pt outcomes. pubmed.ncbi.nlm.nih.gov/40208564/ Smilow Cancer Hospital Yale School of Medicine Yale New Haven Hosp Targeted Oncology

We’re incredibly proud of AACR President Lillian L. Siu Dr. Pat LoRusso for her unwavering support of all patients with cancer and work to advance cancer research, clinical trials, and treatments. #AACR25 Roy Herbst Friends of Cancer Research Abeid Athman (Omar). Smilow Cancer Hospital AACR Yale School of Medicine Yale New Haven Hosp

At the #AACR25 President's Dinner last night, I had the opportunity to thank our distinguished AACR President Patricia M. LoRusso, Pat LoRusso, for her outstanding service to the AACR over the past year. Congratulations, Pat, on a spectacular term as AACR President.

Dr. Patricia LoRusso, AACR President Lillian L. Siu, provides perspective at a panel on sustaining progress against cancer “Cancer Research at a Crossroads” sharing “when #clinicaltrials stall, patients pay the price.” #standingovation 👏🏻👏🏻 #AACR25 AACR Yale School of Medicine YaleClinicalResearch

An emotionally outstanding presentation on AACR President Patricia M. LoRusso Dr. LoRusso’s vision for the future of Oncology and her appreciation for those who encouraged and believed in her, and how she pays this back by leading and inspiring so many more! #AACR25 AACR Yale Cancer Center

Happening now at the DTRF: A New Clinical Trial for Desmoid Tumor Patients:  FOG-001! Desmoid Tumor Research Foundation dtrf.org/event/a-new-cl… Exciting to see new drugs being developed for this disease!

🚨Save the date🚨 ASCO #IMG Community of Practice Meeting at #ASCO25 ⏰May 30st, 4-6 PM CST 📌Room S103, McCormick Place Join us to discuss barriers & opportunities for IMGs ASCO IMG CoP👉bit.ly/3JmJQwK The ASCO Post #IMGoncCoP #MedEd #MedTwitter

Go Curt go! Curt Perry

.Curt Perry presents #ASCO25 on a novel RNA sequencing approach to identify a resistance mechanism enriched in neuroendocrine tumors #NET, merkle cell carcinoma #MCC, and small cell lung cancer #SCLC. Yale Hematology Oncology Fellows Smilow Cancer Hospital OncoAlert meetings.asco.org/2025-asco-annu…

#TrentSelfie

This afternoon at 1:30pm CDT #ASCO25, Juan J. Velasco, MD, Tendai Kwaramba, MD. MSc., and Philippos Apolinario Costa, MD share new research advances from Yale in the final poster session of the day. Smilow Cancer Hospital Yale School of Medicine Yale New Haven Hosp Yale Hematology Oncology Fellows

Look at this legend, literally juggling two posters at the same time on "A Phase II Study of Olaparib in IDH1 and IDH2 Mutant Chondrosarcomas and Other Solid tumors" and "A Phase 2 Study of Olaparib and Ceralasertib in IDH mutant Solid Tumors" at #ASCO25. Dr. Costa, a legend.

.Philippos Apolinario Costa, MD shared results of a phase 2 trial using Olaparib in IDH1 and IDH2 mutant #chondrosarcomas. Olaparib did not demonstrate activity, emphasizing the urgent need for additional therapeutic options. #ASCO25 OncoAlert Smilow Cancer Hospital Yale Hematology Oncology Fellows meetings.asco.org/abstracts-pres…